Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

The COVID-19 pandemic has made it clear that there is a crucial need for the design and development of antiviral agents that can efficiently reduce the fatality rate caused by infectious diseases. The fact that coronavirus mainly enters through the nasal epithelial cells and spreads through the nasa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mali, Avinash, Franci, Gianluigi, Zannella, Carla, Chianese, Annalisa, Anthiya, Shubaash, López-Estévez, Ana M., Monti, Alessandra, De Filippis, Anna, Doti, Nunzianna, Alonso, María José, Galdiero, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305280/
https://www.ncbi.nlm.nih.gov/pubmed/37376070
http://dx.doi.org/10.3390/pharmaceutics15061621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305280/
https://www.ncbi.nlm.nih.gov/pubmed/37376070
http://dx.doi.org/10.3390/pharmaceutics15061621

Ejemplares similares